Neurotoxic effects of venoms from seven species of australasian black snakes (Pseudechis): Efficacy of black and tiger snake antivenoms
Authors:
- 1 January 2005
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 32 (1-2) , 7-12
Abstract
SUMMARY: 1. Pseudechis species (black snakes) are among the most widespread venomous snakes in Australia. Despite this, very little is known about the potency of their venoms or the efficacy of the antivenoms used to treat systemic envenomation by these snakes. The present study investigated the in vitro neurotoxicity of venoms from seven Australasian Pseudechis species and determined the efficacy of black and tiger snake antivenoms against this activity.2. All venoms (10 µg/mL) significantly inhibited indirect twitches of the chick biventer cervicis nerve–muscle preparation and responses to exogenous acetylcholine (ACh; 1 mmol/L), but not to KCl (40 mmol/L), indicating activity at post‐synaptic nicotinic receptors on the skeletal muscle.3. Prior administration of either black or tiger snake antivenom (5 U/mL) prevented the inhibitory effects of all Pseudechis venoms.4. Black snake antivenom (5 U/mL) added at t90 (i.e. the time‐point at which the original twitch height was reduced by 90%) significantly reversed the effects of P. butleri (28 ± 5%), P. guttatus (25 ± 8%) and P. porphyriacus (28 ± 10%) venoms. Tiger snake antivenom (5 U/mL) added at the t90 time‐point significantly reversed the neurotoxic effects of P. guttatus (51 ± 4%), P. papuanus (47 ± 5%) and P. porphyriacus (20 ± 7%) venoms.5. We show, for the first time, the presence of neurotoxins in the venom of these related snake species and that this activity is differentially affected by either black snake or tiger snake antivenoms.Keywords
This publication has 23 references indexed in Scilit:
- Characterisation of a purified phospholipase A2 from the venom of the Papuan black snake (Pseudechis papuanus)Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Neurotoxicity and haemostatic disturbances in patients envenomed by the Papuan black snake (Pseudechis papuanus)Toxicon, 1994
- Biological properties of the venom of the Papuan black snake (Pseudechis papuanus): Presence of a phospholipase A2 platelet inhibitorToxicon, 1994
- Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicksToxicon, 1994
- Neuromuscular effects of four phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snakeToxicon, 1992
- Pathologic changes induced by phospholipase A2 isolated from the venom of Collett's snake, Pseudechis colletti: A light and electron microscopic studyToxicon, 1992
- Antibacterial effects of different snake venoms: Purification and characterization of antibacterial proteins from Pseudechis australis (Australian king brown or mulga snake) venomToxicon, 1991
- Neuromuscular effects of three phospholipases A2 from the venom of the Australian king brown snake Pseudechis australisToxicon, 1989
- A study of the major australian snake venoms in the monkey (Macaca fascicularis): I. the movement of injected venom, methods which retard this movement, and the response to antivenomsPathology, 1981
- RATIONALISATION OF FIRST-AID MEASURES FOR ELAPID SNAKEBITEThe Lancet, 1979